These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32507365)

  • 21. Knowledge and Attitude Toward Human Papillomavirus and HPV Vaccination in Iranian Population: A Systematic Review.
    Taebi M; Riazi H; Keshavarz Z; Afrakhteh M
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):1945-1949. PubMed ID: 31350949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries.
    Burger EA; Portnoy A; Campos NG; Sy S; Regan C; Kim JJ
    Int J Cancer; 2021 Feb; 148(4):932-940. PubMed ID: 32706907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge of cervical cancer and the HPV vaccine.
    Paniagua H
    Br J Nurs; 2006 Feb 9-22; 15(3):126-7. PubMed ID: 16493315
    [No Abstract]   [Full Text] [Related]  

  • 24. Human papillomavirus vaccine disease impact beyond expectations.
    de Sanjose S; Brotons M; LaMontagne DS; Bruni L
    Curr Opin Virol; 2019 Dec; 39():16-22. PubMed ID: 31382121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knowledge of Cervical Cancer, Human Papilloma Virus (HPV) and HPV Vaccination Among Women in Northeast China.
    Ning YE; Liu Y; Xu XY; Zhang XY; Wang N; Zheng LQ
    J Cancer Educ; 2020 Dec; 35(6):1197-1205. PubMed ID: 31338812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
    Yang A; Farmer E; Lin J; Wu TC; Hung CF
    Virus Res; 2017 Mar; 231():148-165. PubMed ID: 27932207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Australian HPV vaccination programme yields results.
    Howe M
    Lancet Oncol; 2014 Dec; 15(13):e591. PubMed ID: 25499291
    [No Abstract]   [Full Text] [Related]  

  • 28. An overview of human papillomaviruses and current vaccine strategies.
    Gnanamony M; Peedicayil A; Abraham P
    Indian J Med Microbiol; 2007 Jan; 25(1):10-7. PubMed ID: 17377346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EUROGIN 2008 roadmap on cervical cancer prevention.
    Franceschi S; Cuzick J; Herrero R; Dillner J; Wheeler CM
    Int J Cancer; 2009 Nov; 125(10):2246-55. PubMed ID: 19521965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expert consensus on immunoprophylaxis of human papillomavirus-related diseases (abridged)].
    Vaccine and Immunization Branch, Chinese Preventive Medicine Association
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Dec; 53(12):1218-1235. PubMed ID: 31795578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV and cervical cancer in the 2007 report.
    WHO/ICO Information Centre on HPV and Cervical Cancer
    Vaccine; 2007 Nov; 25 Suppl 3():C1-230. PubMed ID: 18068032
    [No Abstract]   [Full Text] [Related]  

  • 32. HPV and cervical cancer: screening or vaccination?
    Bosch FX; Castellsagué X; de Sanjosé S
    Br J Cancer; 2008 Jan; 98(1):15-21. PubMed ID: 18182975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of human papillomavirus immunization in the developing world.
    Kane MA; Serrano B; de Sanjosé S; Wittet S
    Vaccine; 2012 Nov; 30 Suppl 5():F192-200. PubMed ID: 23199963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV vaccination strategies targeting hard-to-reach populations: Out-of-school girls in LMICs.
    Bonner K; Banura C; Basta NE
    Vaccine; 2018 Jan; 36(2):191-193. PubMed ID: 29198915
    [No Abstract]   [Full Text] [Related]  

  • 35. Using the new HPV vaccines in clinical practice.
    Widdice LE; Kahn JA
    Cleve Clin J Med; 2006 Oct; 73(10):929-35. PubMed ID: 17044318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
    Poljak M; Šterbenc A; Lunar MM
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPV vaccines: what remains to be done? Interview by Lauren Constable.
    Zur Hausen H
    Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
    [No Abstract]   [Full Text] [Related]  

  • 38. HPV-vaccine and screening programs: the new era of global prevention.
    Mariani L
    J Prev Med Hyg; 2009 Jun; 50(2):90-5. PubMed ID: 20099438
    [No Abstract]   [Full Text] [Related]  

  • 39. Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines.
    Cuschieri K; Brewster DH; Williams AR; Millan D; Murray G; Nicoll S; Imrie J; Hardie A; Graham C; Cubie HA
    Br J Cancer; 2010 Mar; 102(5):930-2. PubMed ID: 20145611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HPV and cervical cancer].
    J Midwifery Womens Health; 2013; 58(2):245-6. PubMed ID: 23451858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.